ESR, CEA, CA 15.3 & EMCA have a role in directing metastatic breast cancer therapy
Keyword(s):
Keyword(s):
2018 ◽
Vol 6
(19)
◽
pp. 3163-3180
◽
Keyword(s):
Keyword(s):
Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy
2018 ◽
Vol 112
◽
pp. 343-355
◽